SGF29 Antikörper (AA 1-293)
Kurzübersicht für SGF29 Antikörper (AA 1-293) (ABIN7168570)
Target
Alle SGF29 (CCDC101) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-293
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human SAGA-associated factor 29 homolog protein (1-293AA)
-
Isotyp
- IgG
-
-
anti-Coiled-Coil Domain Containing 101 (CCDC101) (AA 179-208), (C-Term) antibody
CCDC101 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB26232 unconjugated
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SGF29 (CCDC101) (Coiled-Coil Domain Containing 101 (CCDC101))
-
Andere Bezeichnung
- SGF29
-
Hintergrund
-
Background: Involved in transcriptional regulation, through association with histone acetyltransferase (HAT) SAGA-type complexes like the TFTC-HAT, ATAC or STAGA complexes. Specifically recognizes and binds methylated \\\'Lys-4\\\' of histone H3 (H3K4me), with a preference for trimethylated form (H3K4me3). In the SAGA-type complexes, required to recruit complexes to H3K4me. May be involved in MYC-mediated oncogenic transformation.
Aliases: CCDC101 antibody, Coiled coil domain containing 101 antibody, Coiled coil domain containing protein 101 antibody, Coiled-coil domain-containing protein 101 antibody, FLJ32446 antibody, OTTMUSP00000030606 antibody, SAGA associated factor 29 homolog antibody, SAGA-associated factor 29 homolog antibody, SGF29_HUMAN antibody, STAF36 antibody
-
UniProt
- Q96ES7
Target
-
